Table: Green Peptide -2015/16 parent results

BrightPath Biotherapeutics Co

13/05/2016 08:15

May 13 (Reuters)-  
          Green Peptide Co., Ltd.  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended        Year to        NEXT    
              Mar 31, 2016    Mar 31, 2015    Mar 31, 2017      YEAR      
                 LATEST         YEAR-AGO         COMPANY       COMPANY    
                 RESULTS         RESULTS        FORECAST     H1 FORECAST  
  Sales          822 mln         821 mln         406 mln                  
               (+0.1 pct)                      (-50.5 pct)                
  Operating   loss 988 mln    loss 492 mln      loss 1.31                 
  Recurring   loss 992 mln    loss 413 mln      loss 1.31                 
  Net         loss 994 mln    loss 412 mln      loss 1.31                 
  EPS        loss 35.28 yen  loss 20.60 yen  loss 41.14 yen               
  Ann Div          NIL             NIL             NIL                    
  -Q2 Div          NIL             NIL             NIL                    
  -Q4 Div          NIL             NIL             NIL                    
   
  NOTE - Green Peptide Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T  
  ((Tokyo Headline News Desk +813 6441 1812))